Impact of baseline body mass index on the long-term prognosis of advanced hepatocellular carcinoma treated with immunotherapy

Table 2 Tumor response between body mass index < 25 kg/m² and body mass index ≥ 25 kg/m² groups, n (%)

Variables	BMI < 25 kg/m2 (n = 51)	BMI ≥ 25 kg/m2 (n = 75)	χ2	P value
CR
0	51 (100.00)	73 (97.33)
1	0 (0.00)	1 (1.33)
PR
0	48 (94.12)	56 (74.67)
1	3 (5.88)	19 (25.33)
SD
0	34 (66.67)	49 (65.33)
1	17 (33.33)	26 (36.00)
PD
0	20 (39.22)	47 (62.67)
1	31 (60.78)	28 (37.33)
ORR			9.63	0.002
0	48 (94.12)	54 (72.00)
1	3 (5.88)	21 (28.00)
DCR			6.70	0.010
0	31 (60.78)	28 (37.33)
1	20 (39.22)	47 (64.00)

BMI: Body mass index. CR: Complete response; PR: Partial response; SD: Stable disease; PD: Progression disease; ORR: Objective responds rates; DCR: Disease control rates.